病理性假性缺氧在骨髓增生异常综合征发病机制中的研究

张悦; 肖志坚

doi:10.13201/j.issn.1004-2806.2019.11.001

病理性假性缺氧在骨髓增生异常综合征发病机制中的研究

张悦^1,2,
肖志坚^1, ,

- 中国医学科学院血液病医院(血液学研究所)(天津, 300020)

详细信息

通讯作者: 肖志坚,E-mail:zjxiao@hotmail.com

中图分类号: R733

收稿日期: 2019-08-27

Comments on “Pathobiological Pseudohypoxia as a Putative Mechanism Underlying Myelodysplastic Syndromes”

ZHANG Yue^1,2,
XIAO Zhijian^1, ,

More Information

Corresponding author: XIAO Zhijian, E-mail: zjxiao@hotmail.com

Received Date: 27 August 2019

摘要

- 骨髓增生异常综合征 /
- 低氧诱导因子1A /
- 驱动突变
- myelodysplastic syndromes /
- hypoxia-inducible factor 1α /
- driver mutations

HTML全文

参考文献(16)

[1]	Corey SJ,Minden MD,Barber DL,et al.Myelodysplastic syndromes:the complexity of stem-cell diseases[J].Nat Rev Cancer,2007,7:118-129.
[2]	Tefferi A,Vardiman JW.Myelodysplastic syndromes[J].N Engl J Med,2009,361:1872-1885.
[3]	Zhou T,Kinney MC,Scott LM,et al.Revisiting the case fo genetically engineered mouse models in human myelodysplastic syndrome research[J].Blood,2015,126:1057-1068.
[4]	Nimer SD.Myelodysplastic syndromes[J].Blood,2008,111:4841-4851.
[5]	Raza A,Galili N.The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes[J].Nat Rev Cancer,2012,12:849-859.
[6]	Semenza GL.Targeting HIF-1 for cancer therapy[J].Nat Rev Cancer,2003,3:721-732.
[7]	Takubo K,Goda N,Yamada W,et al.Regulation of the HIF-1alpha level is essential for hematopoietic stem cells[J].Cell Stem Cell,2010,7:391-402.
[8]	Palazon A,Goldrath AW,Nizet V,et al.HIF transcription factors,inflammation,and immunity[J].Immunity,2014,41:518-528.
[9]	Ganan-Gomez I,Wei Y,Starczynowski DT,et al.Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes[J].Leukemia,2015,29:1458-1469.
[10]	Chasis JA,Mohandas N.Erythroblastic islands:niches for erythropoiesis[J].Blood,2008,112:470-478.
[11]	Zhang Y,Yan X,Sashida G,et al.Stress hematopoiesis reveals abnormal control of self-renewal,lineage bias,and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells[J].Blood,2012,120:1118-1129.
[12]	Zhang Y,Chen A,Yan XM,et al.Disordered epigenetic regulation in MLL-related leukemia[J].Int J Hematol,2012,96:428-437.
[13]	Maxwell PH,Wiesener MS,Chang GW,et al.The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis[J].Nature,1999,399:271-275.
[14]	Ravi R,Mookerjee B,Bhujwalla ZM,et al.Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha[J].Genes Dev,2000,14:34-44.
[15]	van Nederveen FH,Korpershoek E,Lenders JW,et al.Somatic SDHB mutation in an extraadrenal pheochromocytoma[J].N Engl J Med,2007,357:306-308.
[16]	Jafri M,Wake NC,Ascher DB,et al.Germline mutations in the CDKN2B tumor suppressor gene predispose to renal cell carcinoma[J].Cancer Discov,2015,5:723-729.